1.Mitophagy regulates bone metabolism
Hanmin ZHU ; Song WANG ; Wenlin XIAO ; Wenjing ZHANG ; Xi ZHOU ; Ye HE ; Wei LI
Chinese Journal of Tissue Engineering Research 2025;29(8):1676-1683
BACKGROUND:In recent years,numerous studies have shown that autophagy and mitophagy play an important role in the regulation of bone metabolism.Under non-physiological conditions,mitophagy breaks the balance of bone metabolism and triggers metabolism disorders,which affect osteoblasts,osteoclasts,osteocytes,chondrocytes,bone marrow mesenchymal stem cells,etc. OBJECTIVE:To summarize the mechanism of mitophagy in regulating bone metabolic diseases and its application in clinical treatment. METHODS:PubMed,Web of Science,CNKI,WanFang and VIP databases were searched by computer using the keywords of"mitophagy,bone metabolism,osteoblasts,osteoclasts,osteocytes,chondrocytes,bone marrow mesenchymal stem cells"in English and Chinese.The search time was from 2008 to 2023.According to the inclusion criteria,90 articles were finally included for review and analysis. RESULTS AND CONCLUSION:Mitophagy promotes the generation of osteoblasts through SIRT1,PINK1/Parkin,FOXO3 and PI3K signaling pathways,while inhibiting osteoclast function through PINK1/Parkin and SIRT1 signaling pathways.Mitophagy leads to bone loss by increasing calcium phosphate particles and tissue protein kinase K in bone tissue.Mitophagy improves the function of chondrocytes through PINK1/Parkin,PI3K/AKT/mTOR and AMPK signaling pathways.Modulation of mitophagy shows great potential in the treatment of bone diseases,but there are still some issues to be further explored,such as different stages of drug-activated mitophagy,and the regulatory mechanisms of different signaling pathways.
2.Clinical features,recurrence risk,and long-term prognosis of anti-myelin oligodendrocyte glycoprotein-IgG associated disorders: An analysis of 91 cases
Journal of Apoplexy and Nervous Diseases 2025;42(4):341-351
Objective To investigate the clinical features and treatment of anti-myelin oligodendrocyte glycoprotein-IgG associated disorders (MOGAD) and the risk factors for recurrence and poor long-term prognosis. Methods A total of 91 patients who were diagnosed with MOGAD in The First Affiliated Hospital of Zhengzhou University from January 2018 to March 2023 were enrolled,and their clinical features and auxiliary examinations were analyzed,as well as the risk factors for recurrence and long-term prognosis. Results Among the 91 patients,69 experienced the first attack of MOGAD,and there were 39 female patients and 47 children (aged<18 years). The proportion of patients with acute disseminated encephalomyelitis among children was significantly higher than that among adults (42.6% vs 18.2%,P=0.012),while the proportion of patients with transverse myelitis among adults was significantly higher than that among children (29.5% vs 2.1%,P<0.001). The proportion of patients receiving hormones combined with immunoglobulins during hospitalization among children was significantly higher than that among adults (36.2% vs 11.4%,P=0.006),and the children had a significantly better Expanded Disability Status Scale (EDSS) score than the adults at discharge [1(0,1) vs 2(0,4.75),P=0.007]. Visual impairment was an independent risk factor for increased recurrence risk (OR=4.215,95%CI 1.236-14.377,P=0.022). A higher EDSS score at discharge (OR=5.05,95%CI 1.27-20.07,P=0.021) and a higher number of attacks (OR=9.235,95%CI 1.352-63.10,P=0.023) were independent factors for poor long-term prognosis,while a steroid maintenance time of >5 weeks at initial diagnosis (OR=0.001,95%CI 0.00-0.33,P=0.001) was an independent factor for improving long-term prognosis. Conclusion For patients newly diagnosed with MOGAD,especially those with a high EDSS score at discharge and features indicating a high risk of recurrence (such as visual impairment),it is recommended that they receive an appropriate course of steroid maintenance treatment after acute-stage treatment.
Recurrence
;
Prognosis
3.The interval of rescue treatment does not affect the efficacy and safety of Helicobacter pylori eradication: A prospective multicenter observational study.
Minjuan LIN ; Junnan HU ; Jing LIU ; Juan WANG ; Zhongxue HAN ; Xiaohong WANG ; Zhenzhen ZHAI ; Yanan YU ; Wenjie YUAN ; Wen ZHANG ; Zhi WANG ; Qingzhou KONG ; Boshen LIN ; Yuming DING ; Meng WAN ; Wenlin ZHANG ; Miao DUAN ; Shuyan ZENG ; Yueyue LI ; Xiuli ZUO ; Yanqing LI
Chinese Medical Journal 2025;138(12):1439-1446
BACKGROUND:
The effect of the interval between previous Helicobacter pylori (H. pylori) eradication and rescue treatment on therapeutic outcomes remains unknown. The aim of this study was to investigate the association between eradication rates and treatment interval durations in H. pylori infections.
METHODS:
This prospective observational study was conducted from December 2021 to February 2023 at six tertiary hospitals in Shandong, China. We recruited patients who were positive for H. pylori infection and required rescue treatment. Demographic information, previous times of eradication therapy, last eradication therapy date, and history of antibiotic use data were collected. The patients were divided into four groups based on the rescue treatment interval length: Group A, ≥4 weeks and ≤3 months; Group B, >3 and ≤6 months; Group C, >6 and ≤12 months; and Group D, >12 months. The primary outcome was the eradication rate of H. pylori . Drug compliance and adverse events (AEs) were also assessed. Pearson's χ2 test or Fisher's exact test was used to compare eradication rates between groups.
RESULTS:
A total of 670 patients were enrolled in this study. The intention-to-treat (ITT) eradication rates were 88.3% (158/179) in Group A, 89.6% (120/134) in Group B, 89.1% (123/138) in Group C, and 87.7% (192/219) in Group D. The per-protocol (PP) eradication rates were 92.9% (156/168) in Group A, 94.5% (120/127) in Group B, 94.5% (121/128) in Group C, and 93.6% (190/203) in Group D. There was no statistically significant difference in the eradication rates between groups in either the ITT ( P = 0.949) or PP analysis ( P = 0.921). No significant differences were observed in the incidence of AEs ( P = 0.934) or drug compliance ( P = 0.849) between groups.
CONCLUSION:
The interval duration of rescue treatment had no significant effect on H. pylori eradication rates or the incidence of AEs.
REGISTRATION
ClinicalTrials.gov , NCT05173493.
Humans
;
Helicobacter Infections/drug therapy*
;
Helicobacter pylori/pathogenicity*
;
Male
;
Female
;
Prospective Studies
;
Middle Aged
;
Anti-Bacterial Agents/adverse effects*
;
Adult
;
Aged
;
Treatment Outcome
;
Proton Pump Inhibitors/therapeutic use*
4.Helicobacter pylori infection status and evolution of gastric cancer.
Wenlin ZHANG ; Yuxin ZHANG ; Jing NING ; Weiwei FU ; Shigang DING
Chinese Medical Journal 2025;138(23):3083-3096
Gastric cancer (GC) is a globally prevalent malignancy with a particularly heavy burden in China. Helicobacter pylori ( H. pylori ) is a Group I carcinogen for GC, with a higher seroprevalence rate indicating a higher GC incidence. However, only approximately 3% of the individuals with H. pylori infection eventually develop GC, and about 2.6% still progress to GC even 10-20 years after the eradication of H. pylori . Thus, the pathogenic mechanism of H. pylori for GC must be elucidated, and high-risk individuals precisely identified. Furthermore, GC can occur even in individuals who have never been infected with H. pylori . As H. pylori infection rates decline, the proportion of H. pylori -negative GC cases is increasing annually, gaining significant research attention. In this review, potential pathogenic mechanisms of H. pylori infection are explored from the aspects of H. pylori virulence factors and host factors (genetic susceptibility and immune microenvironment). Possible risk factors for H. pylori -negative GC include infections by other microorganisms (e.g., bacteria, fungi, and viruses), autoimmune gastritis, bile reflux, genetic mutations, and environmental factors. We aim to review the potential mechanisms for GC with varying H. pylori infection statuses, identify the high-risk individuals, and pose questions that need to be addressed. In the future, as the prevalence of H. pylori infection gradually decreases, GC prevention and management must evolve to address host-specific factors and the growing challenge of H. pylori -negative GC by integrating multidisciplinary perspectives.
Stomach Neoplasms/genetics*
;
Humans
;
Helicobacter Infections/complications*
;
Helicobacter pylori/pathogenicity*
;
Risk Factors
5.NRF2 nuclear translocation and interaction with DUSP1 regulate the osteogenic differentiation of murine mandibular osteoblasts stimulated with Porphyromonas gingivalis lipopolysaccharide.
Xufei YU ; Jiaqi BAO ; Yingming WEI ; Yuting YANG ; Wenlin YUAN ; Lili CHEN ; Zhongxiu WANG
Journal of Zhejiang University. Science. B 2025;26(9):881-896
BACKGROUND: Periodontitis is characterized by alveolar bone resorption, aggravated by osteoblast dysfunction, and associated with intracellular oxidative stress linked to the nuclear factor erythroid 2-related factor 2 (NRF2) level. We evaluated the molecular mechanism of periodontitis onset and development and the role of NRF2 in osteogenic differentiation. METHODS: Primary murine mandibular osteoblasts were extracted and exposed to Porphyromonas gingivalis lipopolysaccharide (Pg-LPS) or other stimuli. Reactive oxygen species (ROS) and 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanine iodide (JC-1) staining were used to detect intracellular oxidative stress. Alkaline phosphatase staining and alizarin red S staining were used to detect the osteogenic differentiation of osteoblasts. Immunofluorescence and western blotting were used to determine the changes in the mitogen-activated protein kinase (MAPK) pathway and related molecule activities. Immunofluorescence colocalization and co-immunoprecipitation were performed to examine the nuclear translocation of NRF2 and its interaction with dual-specific phosphatase 1 (DUSP1) in cells. RESULTS: Ligated tissue samples showed higher alveolar bone resorption rate and lower NRF2 level than healthy periodontal tissue samples. Pg-LPS increased intracellular oxidative stress levels and inhibited osteogenic differentiation, whereas changes in NRF2 expression were correlated with changes in the oxidative stress and osteogenesis rate. NRF2 promoted the dephosphorylation of the MAPK pathway by nuclear translocation and the upregulation of DUSP1 expression, thus enhancing the osteogenic differentiation capacity of mandibular osteoblasts. The interaction between NRF2 and DUSP1 was observed. CONCLUSIONS: NRF2 and its nuclear translocation can regulate the osteogenic differentiation of mandibular osteoblasts under Pg-LPS conditions by interacting with DUSP1 in a process linked to the MAPK pathway. These findings form the basis of periodontitis treatment.
Animals
;
NF-E2-Related Factor 2/physiology*
;
Lipopolysaccharides/pharmacology*
;
Osteoblasts/drug effects*
;
Mice
;
Porphyromonas gingivalis/chemistry*
;
Cell Differentiation
;
Osteogenesis
;
Dual Specificity Phosphatase 1/metabolism*
;
Mandible/cytology*
;
Reactive Oxygen Species/metabolism*
;
Oxidative Stress
;
Periodontitis/metabolism*
;
Cells, Cultured
;
Male
;
Cell Nucleus/metabolism*
6.Research Progress of Glioma in China in 2024
Xiaoman KANG ; Junlin LI ; Wenlin CHEN ; Shanmu JIN ; Yilin LI ; Jiahui LIU ; Yulu GE ; Wenbo WU ; Jiaheng LI ; Yiming LIAN ; Yu WANG ; Wenbin MA
Medical Journal of Peking Union Medical College Hospital 2025;16(6):1437-1448
Glioma is the most common primary malignant tumor of the central nervous system in adults. Despite the standard treatment of surgery combined with radiotherapy and chemotherapy, the prognosis for high-grade glioma patients remains poor, highlighting the urgent need to further explore its pathogenesis and develop new therapeutic strategies. This article reviews the research progress in the field of glioma in China in 2024, covering tumorigenesis mechanisms, tumor immune microenvironment composition, advances in imaging techniques and novel imaging agents, improvements in surgical approaches, mechanisms of radio- and chemoresistance, and explorations of new therapeutic modalities. These studies provide a solid theoretical foundation for advancing clinical diagnosis and treatment of gliomas and may offer new opportunities to improve patient outcomes.
7.Association between heavy metal mixed exposure and neonatal birth weight in pregnancy
Jianzhang ZHAO ; Wenlin BAI ; Miao YUAN ; Meiqi DONG ; Ruiling FANG ; Hongmei YU
Chinese Journal of Preventive Medicine 2024;58(7):1055-1061
The impact of prenatal exposure to a mixture of heavy metals on birth weight in newborns has been a topic of ongoing interest. In this study, 258 mothers and infants from the New Hampshire Birth Cohort Study (NHBCS) were selected as the study subjects, and the concentrations of seven heavy metals in the placenta, including Aluminum (Al), Cobalt (Co), Chromium (Cr), Nickel (Ni), Plumbum (Pb), Selenium (Se) and Arsenic (As) were collected. And the birth weight of newborns, the relevant covariates of mothers and newborns were collected. Three analytical methods, Weighted Quantile Sum (WQS) regression, Quantile g-computation (QGC) and Bayesian kernel machine regression (BKMR) were employed. After adjusting for maternal gestational age, pre-pregnancy BMI, smoking status, education level, parity, gestational age and newborn gender, the combined three methods showed that the total effect of mixed exposure of seven heavy metals on birth weight was negative. Specifically, the WQS analysis revealed that Se had the greatest impact on birth weight, followed by Al. The QGC results showed that the heavy metal associated with the reduction of birth weight was mainly Se and Al in female and male infants, respectively. The BKMR analysis demonstrated a negative combined effect of the seven heavy metals on birth weight in both male and female infants, with Se having the highest posterior inclusion probabilities (PIPs) for female infants (0.45), and Al having the highest PIPs for male infants (0.64) after stratification by gender. In summary, mixed exposure to heavy metals during pregnancy was associated with a decrease in newborn birth weight. Furthermore, there are gender effects with Se and Al associated with decreased birth weight in female and male infants, respectively. These findings provide a theoretical basis for the development of public health policies aimed at preventing adverse pregnancy outcomes and improving the health of newborns.
8.CT features of the recurrent intussusception in pediatric patients after air-enema intestinal reduction and analysis of its influencing factors
Mei YANG ; Wenlin SONG ; Weiwei ZHU ; Yunjian GAO
Journal of Interventional Radiology 2024;33(10):1121-1124
Objective To discuss the CT features of the recurrent intussusception in pediatric patients after air-enema intestinal reduction,and to analyze its influencing factors.Methods The clinical data of child patients with intussusception,whose diagnosis was initially confirmed and treated with air-enema intestinal reduction at the Children's Hospital of Soochow University from January 2020 to May 2022,were retrospectively analyzed.The general data,clinical characteristics and CT imaging findings were collected.Logistic regression analysis was used to determine the factors related to the recurrence of the intussusception.Results A total of 162 child patients were enrolled in this study,among them 103 child patients were males,the mean age was 2.3 years(3 months to 5 years).Thirty-two children(19.75%,recurrent group)developed in-hospital recurrence of intussusception after successful air-enema intestinal reduction.Univariate analysis showed that the incidences of intussusception length,intussusception thickness,target-shaped mass sign,comet's tail sign and enlarged mesenteric lymph nodes in the recurrent group were remarkably higher than those in the non-recurrent group,the differences were statistically significant(all P<0.05).No statistically significant difference in the incidence of ascites existed between the two groups(P>0.05).Multivariate logistic regression analysis revealed that age>3 years(OR=2.10,95%CI=1.25-2.94,P<0.01),enlarged mesenteric lymph nodes(OR=2.05,95%CI=1.07-2.68,P<0.01),and the target-shaped mass sign(OR=3.32,95%CI=1.53-6.62,P<0.01)were the independent influencing factors for the recurrence of intussusception in child patients with intussusception after receiving air-enema intestinal reduction.Conclusion Age>3 years,enlarged mesenteric lymph nodes and target-shaped mass sign are the risk factors for the recurrence of intussusception in child patients with intussusception after receiving air-enema intestinal reduction.
9.Advances in the diagnosis and treatment of acute symptomatic seizures secondary to autoimmune encephalitis and autoimmune-related epilepsy
Wenlin SUN ; Yinyin XIE ; Tingting PENG
Journal of Apoplexy and Nervous Diseases 2024;41(6):515-520
Acute symptomatic seizures secondary to autoimmune encephalitis refers to seizures that occur during the active stage of immune-mediated encephalitis,and autoimmune-related epilepsy refers to disorders with an immune etiol-ogy and a long-term predisposition to unprovoked seizures.Both diseases often have poor response to antiepileptic drugs,and early identification of immune etiology and initiation of immunotherapy may help patients achieve a good prognosis.However,there are no guidelines for the use of drugs in patients with different types of symptomatic seizures,and there is also a lack of diagnostic criteria and treatment principles for autoimmune-related epilepsy.This article reviews and dis-cusses the two diseases from the aspects of possible pathogenesis,clinical manifestations,and recommended treatment methods,so as to provide a theoretical basis for diagnosis and treatment and help to determine future research directions.
10.Mechanism of Sanguis draconis flavones in treatment of myocardial ischemia-reperfusion injury based on network pharmacology
Sheng LI ; Liudan LIANG ; Yan LIU ; Gencheng LIANG ; Wenlin LUO ; Zhaohe HUANG
Chinese Journal of Pathophysiology 2024;40(10):1864-1873
AIM:To predict the mechanism of Sanguis draconis flavones(SDF)in the prevention and treat-ment of myocardial ischemia reperfusion injury(MIRI)based on network pharmacology and molecular docking methods.METHODS:The main chemical constituents of SDF were collected through literature search,and the targets of key con-stituents were screened by using the SwissTargetPrediction and TargetNet databases.Disease targets were also screened based on GeneCards,OMIM,TTD and PharmGkb databases,then targets were intersected with Cytoscape to construct the"drug-key constituent-target"network diagram,and the core target was obtained through visualization and analysis by Cytoscape software.Gene Ontology(GO)functional enrichment and Kyoto Encyclopedia of Genes and Genomes(KEGG)pathway enrichment analyses were analyzed by the Metascape platform.By utilizing AutoDock Vina software and Pymol,molecular docking between core compounds and core targets was carried out.Further,animal experiments were performed to explore the pharmacodynamic mechanism of SDF.RESULTS:The active constituents of SDF included loureirin B and loureirin A,which were mapped to 391 targets.A total of 3 096 MIRI disease targets were obtained from the database,af-ter intersection,172 intersection targets were obtained,and 56 core targets were acquired through analysis.The core relat-ed pathways included the cancer pathway and cell death signaling pathway.The results of molecular docking verified the strong binding activity between key constituents and key targets.Animal experiments demonstrated that SDF effectively prevented and treated MIRI,significantly inhibited the arachidonic acid 15-lipoxygenase(ALOX15)mRNA and protein expression,and reduced the myocardial infarction size after MIRI.CONCLUSION:SDF may play a positive role in the treatment of MIRI,which may be related to the regulation of the ALOX15 factor.

Result Analysis
Print
Save
E-mail